WEBULL

Ercros (BME:ECR) Stock Returns To Profit But Durability Remains Unclear

Simply Wall St · 1d ago

Ercros stock closed at €3.485, with recent returns barely moving the needle over the past week and month. The share price looks calm on the surface. The earnings print is anything but. Q2 revenue landed at €214.397 million and flipped the company back into profit with net income of €9.705 million, after a run of quarterly losses.

For a chemicals producer that has been unprofitable over the last twelve months and is expected to stay that way in forecasts, this single profitable quarter stands out. The real question now is how durable that profit turn proves to be.

Is Ercros now a genuine bargain on 0.5x P/S, or is the market rightly worried about continued losses and debt? See how the numbers line up in our valuation analysis for Ercros

Q2 2026 Earnings Summary

  • Revenue, Q2 2026 vs. Q2 2025: €214.397 million vs. €168.012 million (higher year on year)
  • Net Income, Q2 2026 vs. Q2 2025: profit of €9.705 million vs. loss of €17.107 million (returned to profit from a loss)
  • Basic EPS, Q2 2026 vs. Q2 2025: not disclosed for Q2 2026 vs. loss per share of €0.187092 in Q2 2025 (shift from a loss per share, exact Q2 2026 figure not provided)

Prefer clean, visual charts to a wall of earnings tables and footnotes? See Ercros' full financial picture, with a focus on its recent profit return and how it fits into the broader results in our company report for Ercros.

BME:ECR Trailing 12-Month Revenue & Expenses Breakdown as at Jul 2026
BME:ECR Trailing 12-Month Revenue & Expenses Breakdown as at Jul 2026

Ercros bullish signals from revenue and profit shift

For anyone leaning positive on Ercros, this quarter gives some backing. Revenue of €214.397 million sits well ahead of the prior year period and the business moved from a loss to a €9.705 million profit. That aligns with a narrative of a diversified chemicals and pharma platform that can return to the black when conditions are supportive. The modestly positive 7 day, 30 day and 90 day share returns, while small, also suggest investors have not reacted negatively to these numbers.

Ercros risks around consistency and past losses

The cautionary side of the story still matters for Ercros. The company has been loss making over the last twelve months and is expected in forecasts to remain unprofitable, so a single profitable quarter does not yet rewrite the track record. Net income has only just moved back into positive territory and earnings per share are not disclosed for Q2 2026. That leaves questions about how robust this earnings level is across segments that depend heavily on industrial demand and pricing.

After a year of losses and with Ercros carrying a high level of debt, are these fresh profits masking deeper structural pressures, or just the start of more volatility ahead? Review our independent risk analysis for Ercros which shows 1 important warning sign

Stay Ahead With Simply Wall St

If Ercros' return to profit has your attention, register for free with Simply Wall St and add it to a Watchlist to track its share price against fair value and watch for a more attractive entry point. Once you hold the stock, use the Portfolio Command Center to cut through market noise and focus on the updates that really matter to your investment case. For a broader view, tap into crowd insight through the Community and see how other investors are thinking about Ercros and similar stocks. By spotting potential catalysts and risks early, you give yourself a better chance of staying ahead of the market.

Seeking Alternatives Beyond Ercros?

Fresh ideas move fast. Some stocks build quiet momentum, others set up for a breakout while they are still under the radar for now. Do not get caught waiting, act now.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.